dr. wolf on the design of geometry mono-1 trial in metex14-mutated nsclc
Published 4 years ago • 164 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:25
dr. wolf on updated findings with capmatinib in metex14-mutant nsclc
-
2:38
dr. wolf discusses the geometry study in met nsclc
-
1:53
phase ii results of the geometry mono-1 study in nsclc
-
0:43
geometry study confirms importance of testing for metex14 alteration in advanced nsclc
-
0:59
dr. kerrigan on design and findings of the profile 1001 trial in ros1-mutated nsclc
-
1:11
dr. awad on objectives of the phase 2 geometry mono-1 study in nsclc
-
1:54
dr. le on the rationale for tepotinib in metex14-mutant nsclc
-
0:49
the importance of metex14 testing in nsclc
-
2:49
the challenges of treating metex14 nsclc
-
1:19
dr. chaft on predictive biomarkers in lung cancer
-
8:47
brain case of the day 35
-
13:46
dr navdeep singh | capmatinib unlocking the unmet need in metex14 skipping nsclc
-
1:32
assessing capmatinib for lung cancer
-
4:35
tabrecta - lung cancer treatment
-
1:04
dmitry pyatetsky, md
-
2:19
inequalities in biomarker testing
-
5:09
biodesign - rational bioactive materials design for tissue generation
-
19:08
dr. greg davis's most interesting rhinology case
-
4:40
univers vaultlock® augmented glenoid cadaveric demonstration